Johnson & Johnson JNJ:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD

After Hours: Last | 5:41 AM EDT

145.59

-0.15 (-0.10%)

Volume

2,773

145.74

+0.97 (+0.67%)

Volume

8,751,936

52 week range

143.13 - 175.97

Open0.00
Day High0.00
Day Low0.00
Prev Close145.74
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24

Key Stats

Market Cap351.202B
Shares Out2.41B
10 Day Average Volume7.87M
Dividend4.96
Dividend Yield3.40%
Beta0.54
YTD % Change-7.02

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close145.74
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24
Market Cap351.202B
Shares Out2.41B
10 Day Average Volume7.87M
Dividend4.96
Dividend Yield3.40%
Beta0.54
YTD % Change-7.02

RATIOS/PROFITABILITY

EPS (TTM)7.55
P/E (TTM)19.30
Fwd P/E (NTM)13.77
EBITDA (TTM)29.873B
ROE (TTM)18.31%
Revenue (TTM)81.796B
Gross Margin (TTM)70.22%
Net Margin (TTM)22.92%
Debt To Equity (MRQ)42.65%

EVENTS

Earnings Date07/17/2024(est)
Ex Div Date05/20/2024
Div Amount1.24
Split Date-
Split Factor-

Latest On Johnson & Johnson

What stands in the way of stocks breaking free of the volatility we've been seeingApril 16, 2024CNBC.com
Stocks on the move: UnitedHealth and Johnson & JohnsonApril 16, 2024CNBC.com
Stocks making big midday moves: UnitedHealth, Bank of America, Tesla and more April 16, 2024CNBC.com
10 things to watch in the stock market Tuesday: Morgan Stanley beats, Nvidia callApril 16, 2024CNBC.com
Stocks making the biggest moves premarket: Morgan Stanley, UnitedHealth, Live Nation and moreApril 16, 2024CNBC.com

Content From Our Affiliates

Hold Rating on Johnson & Johnson Amidst Growth, Competition, and Legal ChallengesApril 18, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)April 18, 2024TipRanks
Johnson & Johnson price target lowered to $175 from $181 at RBC CapitalApril 17, 2024TipRanks
Johnson & Johnson price target lowered to $170 from $180 at BofAApril 17, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI)April 17, 2024TipRanks

Profile

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...

Joaquin Duato

Chairman of the Board, Chief Executive Officer

Joseph Wolk

Chief Financial Officer, Executive Vice President

Tim Schmid

Executive Vice President, Worldwide Chairman of MedTech

Elizabeth Forminard

Executive Vice President, General Counsel

John Reed M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

Address

One Johnson & Johnson Plaza

New Brunswick, NJ

08933

United States

https://www.jnj.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	125.23	-0.14	-0.11%
ABBV AbbVie Inc	164.66	+0.41	+0.25%
RHHBY Roche Holding AG	30.05	UNCH	UNCH
AZN AstraZeneca PLC	68.36	-0.17	-0.25%
NVS Novartis AG	92.57	-0.51	0.00%